artesunic acid has been researched along with Bacteremia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Obaro, SK | 1 |
| Anstey, NM; Barber, BE; Menon, J; Rajahram, GS; William, T; Yeo, TW | 1 |
| Cao, H; Ding, G; Dong, Y; He, S; Jiang, W; Li, B; Li, J; Lu, Y; Luo, P; Zhang, L; Zhang, R; Zheng, J; Zhou, H | 1 |
3 other study(ies) available for artesunic acid and Bacteremia
| Article | Year |
|---|---|
Artesunate for severe malaria in African children.
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Bacteremia; Child; Child, Preschool; Humans; Malaria; Parasitemia; Severity of Illness Index | 2011 |
Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as Plasmodium malariae and delayed parenteral artesunate.
Topics: Adult; Aged; Antimalarials; Artemisinins; Artesunate; Bacteremia; Diagnostic Errors; Female; Gram-Negative Bacterial Infections; Humans; Malaria; Malaysia; Male; Middle Aged; Plasmodium knowlesi; Plasmodium malariae | 2012 |
Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Bacteremia; Cells, Cultured; Endotoxins; Escherichia coli Infections; Female; Interleukin-6; Male; Mice; NF-kappa B; Oligodeoxyribonucleotides; RNA, Messenger; Sesquiterpenes; Toll-Like Receptor 4; Toll-Like Receptor 9; Tumor Necrosis Factor-alpha | 2008 |